BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

September 18, 2023 | News

Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling

The product is built upon Singleron's molecular barcoding technology, enabling multiplexing of 96 or 384 samples in a single library construction reaction....

September 14, 2023 | News

Lunit Study Backs AI as Effective Alternative to Single Human Reader in European Double Reading System

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is spearheading a transformative change in...

September 12, 2023 | News

Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced the establishment of a collaboration and exclusive...

September 11, 2023 | News

Genmab and Seagen Report TIVDAK® Success in Cervical Cancer Survival Trial

Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...

September 05, 2023 | News

Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore

Agilent Technologies Inc. (NYSE: A) recently signed a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institu...

September 05, 2023 | News

Thyme Care Secures $60M Series B to Scale Cancer Care Beyond the Clinic

Oncology care innovator streamlines a notoriously fragmented healthcare system, reducing gaps and barriers to care for chronically under supp...

September 04, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing. The financ...

September 04, 2023 | News

HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer

The study of savolitinib is a single-arm, multi-center, open-label, Phase II registration study to evaluate the efficacy, safety and tolerability of savoli...

August 29, 2023 | News

Zhiyi Biotech Begins Phase 1 Trial of SK10 for Chemo-induced Diarrhea

SK10, the first Bacteroides fragilis-based live biotherapeutic product (LBP) obtained FDA IND approval, is also the first LBP of Next-generation probi...

August 28, 2023 | News

Agenus Focuses on Fast-Tracking BOT/BAL Program for Cancer

Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a pioneer in immuno-oncology, today announced a strategic initiative to prioritize and focus resources t...

August 24, 2023 | News

Oracle Joins White House CancerX Initiative to Aid in the Fight Against Cancer

Oracle has been recognized as a founding member of CancerX. The public-private partnership was formed to drive innovations that can help reduce deaths...

August 23, 2023 | News

Mammotome Unveils HydroMARK™ Plus: Innovative Breast Biopsy Site Marker

"I am excited for this innovative biopsy marker to come to market," said Radiologist Dr. Evita Singh, Director of Breast Imaging at Karmanos Cancer In...

August 22, 2023 | News

Verily and OneOncology Announce Collaboration to Advance Cancer Research

Verily, an Alphabet precision health technology company, and OneOncology, the national platform for independent oncology practices, have established a stra...

August 17, 2023 | News

Stay Connected